Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 193

1.

HPV-Related Multiphenotypic Sinonasal Carcinoma: Four Cases that Expand the Morpho-Molecular Spectrum and Include Occupational Data.

Rupp NJ, Camenisch U, Seidl K, Rushing EJ, Anderegg N, Broglie MA, Holzmann D, Morand GB.

Head Neck Pathol. 2019 Sep 30. doi: 10.1007/s12105-019-01079-1. [Epub ahead of print]

PMID:
31571045
2.

Enhanced detection of prion infectivity from blood by preanalytical enrichment with peptoid-conjugated beads.

Hornemann S, Schwarz P, Rushing EJ, Connolly MD, Zuckermann RN, Yam AY, Aguzzi A.

PLoS One. 2019 Sep 12;14(9):e0216013. doi: 10.1371/journal.pone.0216013. eCollection 2019.

3.

A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis.

Johnson DB, McDonnell WJ, Gonzalez-Ericsson PI, Al-Rohil RN, Mobley BC, Salem JE, Wang DY, Sanchez V, Wang Y, Chastain CA, Barker K, Liang Y, Warren S, Beechem JM, Menzies AM, Tio M, Long GV, Cohen JV, Guidon AC, O'Hare M, Chandra S, Chowdhary A, Lebrun-Vignes B, Goldinger SM, Rushing EJ, Buchbinder EI, Mallal SA, Shi C, Xu Y, Moslehi JJ, Sanders ME, Sosman JA, Balko JM.

Nat Med. 2019 Aug;25(8):1243-1250. doi: 10.1038/s41591-019-0523-2. Epub 2019 Jul 22.

PMID:
31332390
4.

Adjuvant Chemotherapy Increases Programmed Death-Ligand 1 (PD-L1) Expression in Non-small Cell Lung Cancer Recurrence.

Lacour M, Hiltbrunner S, Lee SY, Soltermann A, Rushing EJ, Soldini D, Weder W, Curioni-Fontecedro A.

Clin Lung Cancer. 2019 Sep;20(5):391-396. doi: 10.1016/j.cllc.2019.05.013. Epub 2019 Jun 5.

PMID:
31262689
5.

Active receptor tyrosine kinases, but not Brachyury, are sufficient to trigger chordoma in zebrafish.

D'Agati G, Cabello EM, Frontzek K, Rushing EJ, Klemm R, Robinson MD, White RM, Mosimann C, Burger A.

Dis Model Mech. 2019 Jul 16;12(7). pii: dmm039545. doi: 10.1242/dmm.039545.

6.

Eight autopsy cases of melanoma brain metastases showing angiotropism and pericytic mimicry. Implications for extravascular migratory metastasis.

Rodewald AK, Rushing EJ, Kirschenbaum D, Mangana J, Mittmann C, Moch H, Lugassy C, Barnhill RL, Mihic-Probst D.

J Cutan Pathol. 2019 Aug;46(8):570-578. doi: 10.1111/cup.13465. Epub 2019 Apr 16.

PMID:
30927294
7.

An Infratentorial Tumor in a 44-Year-Old Female Patient.

Losa M, Carta MC, Frontzek K, Krayenbühl N, Wichmann W, Rushing EJ.

Brain Pathol. 2019 Jan;29(1):145-146. doi: 10.1111/bpa.12684. No abstract available.

PMID:
30600598
8.

A 72-year old female with multiple supra- and infratentorial dural masses.

Kirschenbaum D, Woernle C, Haralambieva E, Marques Maggio E, Bernays R, Camenisch U, Rushing EJ.

Brain Pathol. 2018 Nov;28(6):1023-1024. doi: 10.1111/bpa.12666. No abstract available.

PMID:
30536772
9.

Post-operative cardiovascular complications and time to recurrence in meningioma patients treated with versus without pre-operative embolization: a retrospective cohort study of 741 patients.

Wirsching HG, Richter JK, Sahm F, Morel C, Krayenbuehl N, Rushing EJ, von Deimling A, Valavanis A, Weller M.

J Neurooncol. 2018 Dec;140(3):659-667. doi: 10.1007/s11060-018-2996-0. Epub 2018 Sep 8.

PMID:
30196368
10.

TGF-β Determines the Pro-migratory Potential of bFGF Signaling in Medulloblastoma.

Santhana Kumar K, Neve A, Guerreiro Stucklin AS, Kuzan-Fischer CM, Rushing EJ, Taylor MD, Tripolitsioti D, Behrmann L, Kirschenbaum D, Grotzer MA, Baumgartner M.

Cell Rep. 2018 Jun 26;23(13):3798-3812.e8. doi: 10.1016/j.celrep.2018.05.083.

11.

MAP4K4 controlled integrin β1 activation and c-Met endocytosis are associated with invasive behavior of medulloblastoma cells.

Tripolitsioti D, Kumar KS, Neve A, Migliavacca J, Capdeville C, Rushing EJ, Ma M, Kijima N, Sharma A, Pruschy M, McComb S, Taylor MD, Grotzer MA, Baumgartner M.

Oncotarget. 2018 May 1;9(33):23220-23236. doi: 10.18632/oncotarget.25294. eCollection 2018 May 1.

12.

New observations in tumor cell plasticity: mutational profiling in a case of metastatic melanoma with biphasic sarcomatoid transdifferentiation.

Rupp NJ, Rechsteiner M, Freiberger SN, Lenggenhager D, Urosevic M, Burger IA, Rushing EJ, Mihic-Probst D.

Virchows Arch. 2018 Oct;473(4):517-521. doi: 10.1007/s00428-018-2376-3. Epub 2018 May 21.

PMID:
29785541
13.

Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial.

Wirsching HG, Tabatabai G, Roelcke U, Hottinger AF, Jörger F, Schmid A, Plasswilm L, Schrimpf D, Mancao C, Capper D, Conen K, Hundsberger T, Caparrotti F, von Moos R, Riklin C, Felsberg J, Roth P, Jones DTW, Pfister S, Rushing EJ, Abrey L, Reifenberger G, Held L, von Deimling A, Ochsenbein A, Weller M.

Ann Oncol. 2018 Jun 1;29(6):1423-1430. doi: 10.1093/annonc/mdy120.

PMID:
29648580
14.

Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological study.

Gramatzki D, Roth P, Rushing EJ, Weller J, Andratschke N, Hofer S, Korol D, Regli L, Pangalu A, Pless M, Oberle J, Bernays R, Moch H, Rohrmann S, Weller M.

Ann Oncol. 2018 Jun 1;29(6):1431-1436. doi: 10.1093/annonc/mdy106.

PMID:
29617713
15.

Age-associated and therapy-induced alterations in the cellular microenvironment of experimental gliomas.

Schneider H, Lohmann B, Wirsching HG, Hasenbach K, Rushing EJ, Frei K, Pruschy M, Tabatabai G, Weller M.

Oncotarget. 2017 Aug 3;8(50):87124-87135. doi: 10.18632/oncotarget.19894. eCollection 2017 Oct 20.

16.

IDH-mutant giant cell glioblastoma: A neglected tumor variant?

Leske H, Brandal P, Rushing EJ, Niehusmann P.

Clin Neuropathol. 2017 Nov/Dec;36(6):293-295. doi: 10.5414/NP301054. No abstract available.

PMID:
29035191
17.

Neurologic Injury With Severe Adult Respiratory Distress Syndrome in Patients Undergoing Extracorporeal Membrane Oxygenation: A Single-Center Retrospective Analysis.

Klinzing S, Wenger U, Stretti F, Steiger P, Rushing EJ, Schwarz U, Maggiorini M.

Anesth Analg. 2017 Nov;125(5):1544-1548. doi: 10.1213/ANE.0000000000002431. Review.

18.

Fibrin-associated diffuse large B-cell lymphoma in a hemorrhagic cranial arachnoid cyst.

Kirschenbaum D, Prömmel P, Vasella F, Haralambieva E, Marques Maggio E, Reisch R, Beer M, Camenisch U, Rushing EJ.

Acta Neuropathol Commun. 2017 Aug 7;5(1):60. doi: 10.1186/s40478-017-0463-3. No abstract available.

19.

Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 cases.

Schnitzler LJ, Schreckenbach T, Nadaj-Pakleza A, Stenzel W, Rushing EJ, Van Damme P, Ferbert A, Petri S, Hartmann C, Bornemann A, Meisel A, Petersen JA, Tousseyn T, Thal DR, Reimann J, De Jonghe P, Martin JJ, Van den Bergh PY, Schulz JB, Weis J, Claeys KG.

Orphanet J Rare Dis. 2017 May 11;12(1):86. doi: 10.1186/s13023-017-0640-2. Review.

20.

The epileptology of Koolen-de Vries syndrome: Electro-clinico-radiologic findings in 31 patients.

Myers KA, Mandelstam SA, Ramantani G, Rushing EJ, de Vries BB, Koolen DA, Scheffer IE.

Epilepsia. 2017 Jun;58(6):1085-1094. doi: 10.1111/epi.13746. Epub 2017 Apr 25.

21.

Isolated intracerebral Langerhans cell histiocytosis with multifocal lesions.

Velz J, Neidert MC, Bozinov O, Grotzer M, Kirschenbaum D, Rushing EJ.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26546. Epub 2017 Apr 24. No abstract available.

PMID:
28436595
22.

Durable Control of Metastatic AKT1-Mutant WHO Grade 1 Meningothelial Meningioma by the AKT Inhibitor, AZD5363.

Weller M, Roth P, Sahm F, Burghardt I, Schuknecht B, Rushing EJ, Regli L, Lindemann JP, von Deimling A.

J Natl Cancer Inst. 2017 Mar 1;109(3):1-4. doi: 10.1093/jnci/djw320.

23.

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.

Sahm F, Schrimpf D, Stichel D, Jones DTW, Hielscher T, Schefzyk S, Okonechnikov K, Koelsche C, Reuss DE, Capper D, Sturm D, Wirsching HG, Berghoff AS, Baumgarten P, Kratz A, Huang K, Wefers AK, Hovestadt V, Sill M, Ellis HP, Kurian KM, Okuducu AF, Jungk C, Drueschler K, Schick M, Bewerunge-Hudler M, Mawrin C, Seiz-Rosenhagen M, Ketter R, Simon M, Westphal M, Lamszus K, Becker A, Koch A, Schittenhelm J, Rushing EJ, Collins VP, Brehmer S, Chavez L, Platten M, Hänggi D, Unterberg A, Paulus W, Wick W, Pfister SM, Mittelbronn M, Preusser M, Herold-Mende C, Weller M, von Deimling A.

Lancet Oncol. 2017 May;18(5):682-694. doi: 10.1016/S1470-2045(17)30155-9. Epub 2017 Mar 15.

24.

A 49-year old female with multiple extra-axial tumors.

Neidert MC, Leske H, Frontzek K, Bode B, Capper D, Regli L, Rushing EJ.

Brain Pathol. 2017 Mar;27(2):235-236. doi: 10.1111/bpa.12488. No abstract available.

PMID:
28217955
25.

Diagnostic red flags: steroid-treated malignant CNS lymphoma mimicking autoimmune inflammatory demyelination.

Barrantes-Freer A, Engel AS, Rodríguez-Villagra OA, Winkler A, Bergmann M, Mawrin C, Kuempfel T, Pellkofer H, Metz I, Bleckmann A, Hernández-Durán S, Schippling S, Rushing EJ, Frank S, Glatzel M, Matschke J, Hartmann C, Reifenberger G, Müller W, Schildhaus HU, Brück W, Stadelmann C.

Brain Pathol. 2018 Mar;28(2):225-233. doi: 10.1111/bpa.12496. Epub 2017 Apr 6.

PMID:
28213912
26.

Protease resistance of infectious prions is suppressed by removal of a single atom in the cellular prion protein.

Leske H, Hornemann S, Herrmann US, Zhu C, Dametto P, Li B, Laferriere F, Polymenidou M, Pelczar P, Reimann RR, Schwarz P, Rushing EJ, Wüthrich K, Aguzzi A.

PLoS One. 2017 Feb 16;12(2):e0170503. doi: 10.1371/journal.pone.0170503. eCollection 2017.

27.

Cystatin F is a biomarker of prion pathogenesis in mice.

Nuvolone M, Schmid N, Miele G, Sorce S, Moos R, Schori C, Beerli RR, Bauer M, Saudan P, Dietmeier K, Lachmann I, Linnebank M, Martin R, Kallweit U, Kana V, Rushing EJ, Budka H, Aguzzi A.

PLoS One. 2017 Feb 8;12(2):e0171923. doi: 10.1371/journal.pone.0171923. eCollection 2017.

28.

Sudan black: a fast, easy and non-toxic method to assess myelin repair in demyelinating diseases.

Ineichen BV, Weinmann O, Good N, Plattner PS, Wicki C, Rushing EJ, Linnebank M, Schwab ME.

Neuropathol Appl Neurobiol. 2017 Apr;43(3):242-251. doi: 10.1111/nan.12373. Epub 2017 Mar 10.

PMID:
28009439
29.

Suprasellar pilocytic astrocytoma in an adult with hemorrhage and leptomeningeal dissemination: case report and review of literature.

Soliman RK, Budai C, Mundada P, Aljohani B, Rushing EJ, Kollias SS.

Radiol Case Rep. 2016 Sep 29;11(4):411-418. eCollection 2016 Dec.

30.

MicroRNA deep sequencing in two adult stem cell populations identifies miR-501 as a novel regulator of myosin heavy chain during muscle regeneration.

Mizbani A, Luca E, Rushing EJ, Krützfeldt J.

Development. 2016 Nov 15;143(22):4137-4148. Epub 2016 Oct 5.

31.

Exercise effects in Huntington disease.

Frese S, Petersen JA, Ligon-Auer M, Mueller SM, Mihaylova V, Gehrig SM, Kana V, Rushing EJ, Unterburger E, Kägi G, Burgunder JM, Toigo M, Jung HH.

J Neurol. 2017 Jan;264(1):32-39. doi: 10.1007/s00415-016-8310-1. Epub 2016 Oct 17.

PMID:
27747393
32.

Morphological and molecular features of astroblastoma, including BRAFV600E mutations, suggest an ontological relationship to other cortical-based gliomas of children and young adults.

Lehman NL, Hattab EM, Mobley BC, Usubalieva A, Schniederjan MJ, McLendon RE, Paulus W, Rushing EJ, Georgescu MM, Couce M, Dulai MS, Cohen ML, Pierson CR, Raisanen JM, Martin SE, Lehman TD, Lipp ES, Bonnin JM, Al-Abbadi MA, Kenworthy K, Zhao K, Mohamed N, Zhang G, Zhao W.

Neuro Oncol. 2017 Jan;19(1):31-42. doi: 10.1093/neuonc/now118. Epub 2016 Jul 14.

33.

Cutaneous Melanoma with Brain Metastasis: Report of 193 Patients with New Observations.

Gugger A, Barnhill RL, Seifert B, Dehler S, Moch H, Lugassy C, Marques-Maggio E, Rushing EJ, Mihic-Probst D.

PLoS One. 2016 May 23;11(5):e0156115. doi: 10.1371/journal.pone.0156115. eCollection 2016.

34.

Evaluation of NADPH oxidases as drug targets in a mouse model of familial amyotrophic lateral sclerosis.

Seredenina T, Nayernia Z, Sorce S, Maghzal GJ, Filippova A, Ling SC, Basset O, Plastre O, Daali Y, Rushing EJ, Giordana MT, Cleveland DW, Aguzzi A, Stocker R, Krause KH, Jaquet V.

Free Radic Biol Med. 2016 Aug;97:95-108. doi: 10.1016/j.freeradbiomed.2016.05.016. Epub 2016 May 19.

35.

A neuroprotective role for microglia in prion diseases.

Zhu C, Herrmann US, Falsig J, Abakumova I, Nuvolone M, Schwarz P, Frauenknecht K, Rushing EJ, Aguzzi A.

J Exp Med. 2016 May 30;213(6):1047-59. doi: 10.1084/jem.20151000. Epub 2016 May 16.

36.

Chemotherapy for intracranial ependymoma in adults.

Gramatzki D, Roth P, Felsberg J, Hofer S, Rushing EJ, Hentschel B, Westphal M, Krex D, Simon M, Schnell O, Wick W, Reifenberger G, Weller M.

BMC Cancer. 2016 Apr 23;16:287. doi: 10.1186/s12885-016-2323-0.

37.

Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009.

Gramatzki D, Dehler S, Rushing EJ, Zaugg K, Hofer S, Yonekawa Y, Bertalanffy H, Valavanis A, Korol D, Rohrmann S, Pless M, Oberle J, Roth P, Ohgaki H, Weller M.

Cancer. 2016 Jul 15;122(14):2206-15. doi: 10.1002/cncr.30023. Epub 2016 Apr 18.

38.

Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivo.

Szabo E, Schneider H, Seystahl K, Rushing EJ, Herting F, Weidner KM, Weller M.

Neuro Oncol. 2016 Sep;18(9):1242-52. doi: 10.1093/neuonc/now043. Epub 2016 Mar 23.

39.

MicroRNA-29a in Adult Muscle Stem Cells Controls Skeletal Muscle Regeneration During Injury and Exercise Downstream of Fibroblast Growth Factor-2.

Galimov A, Merry TL, Luca E, Rushing EJ, Mizbani A, Turcekova K, Hartung A, Croce CM, Ristow M, Krützfeldt J.

Stem Cells. 2016 Mar;34(3):768-80. doi: 10.1002/stem.2281. Epub 2016 Jan 29.

40.

Predicting outcome of epilepsy after meningioma resection.

Wirsching HG, Morel C, Gmür C, Neidert MC, Baumann CR, Valavanis A, Rushing EJ, Krayenbühl N, Weller M.

Neuro Oncol. 2016 Jul;18(7):1002-10. doi: 10.1093/neuonc/nov303. Epub 2015 Dec 18.

41.

The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway.

Silginer M, Burghardt I, Gramatzki D, Bunse L, Leske H, Rushing EJ, Hao N, Platten M, Weller M, Roth P.

Oncogene. 2016 Jun 23;35(25):3260-71. doi: 10.1038/onc.2015.387. Epub 2015 Oct 26.

PMID:
26500056
42.

Synchronous pituitary adenoma and pituicytoma.

Neidert MC, Leske H, Burkhardt JK, Kollias SS, Capper D, Schrimpf D, Regli L, Rushing EJ.

Hum Pathol. 2016 Jan;47(1):138-43. doi: 10.1016/j.humpath.2015.08.017. Epub 2015 Sep 16.

PMID:
26476569
43.

Dysferlinopathy in Switzerland: clinical phenotypes and potential founder effects.

Petersen JA, Kuntzer T, Fischer D, von der Hagen M, Huebner A, Kana V, Lobrinus JA, Kress W, Rushing EJ, Sinnreich M, Jung HH.

BMC Neurol. 2015 Oct 6;15:182. doi: 10.1186/s12883-015-0449-3.

44.

Towards an integrated morphological and molecular WHO diagnosis of central nervous system tumors: a paradigm shift.

Rushing EJ, Wesseling P.

Curr Opin Neurol. 2015 Dec;28(6):628-32. doi: 10.1097/WCO.0000000000000258. Review.

PMID:
26402407
45.

Heterogeneous Appearance of Central Nervous System Involvement in Malignant Mixed Müllerian Tumors.

Könnecke HK, Rushing EJ, Neidert MC, Reimann R, Regli L, Bozinov O, Burkhardt JK.

J Neurol Surg A Cent Eur Neurosurg. 2016 Sep;77(5):447-51. doi: 10.1055/s-0035-1558412. Epub 2015 Jul 27.

46.

Evidence-Based Diagnostic Algorithm for Glioma: Analysis of the Results of Pathology Panel Review and Molecular Parameters of EORTC 26951 and 26882 Trials.

Kros JM, Huizer K, Hernández-Laín A, Marucci G, Michotte A, Pollo B, Rushing EJ, Ribalta T, French P, Jaminé D, Bekka N, Lacombe D, van den Bent MJ, Gorlia T.

J Clin Oncol. 2015 Jun 10;33(17):1943-50. doi: 10.1200/JCO.2014.59.0166. Epub 2015 Apr 27.

PMID:
25918297
47.

Transforming growth factor-β pathway activity in glioblastoma.

Frei K, Gramatzki D, Tritschler I, Schroeder JJ, Espinoza L, Rushing EJ, Weller M.

Oncotarget. 2015 Mar 20;6(8):5963-77.

48.

Triggering receptor expressed on myeloid cells-2 is involved in prion-induced microglial activation but does not contribute to prion pathogenesis in mouse brains.

Zhu C, Herrmann US, Li B, Abakumova I, Moos R, Schwarz P, Rushing EJ, Colonna M, Aguzzi A.

Neurobiol Aging. 2015 May;36(5):1994-2003. doi: 10.1016/j.neurobiolaging.2015.02.019. Epub 2015 Feb 27.

PMID:
25816748
49.

Efficacy of Surgery and Further Treatment of Progressive Glioblastoma.

Woernle CM, Péus D, Hofer S, Rushing EJ, Held U, Bozinov O, Krayenbühl N, Weller M, Regli L.

World Neurosurg. 2015 Aug;84(2):301-7. doi: 10.1016/j.wneu.2015.03.018. Epub 2015 Mar 19.

50.

A 44-year old male with right-sided facial numbness. Dura-associated extranodal marginal zone B cell lymphoma (MALT lymphoma).

Neidert MC, Leske H, Burkhardt JK, Rushing EJ, Bozinov O.

Brain Pathol. 2015 Jan;25(1):113-4. doi: 10.1111/bpa.12234. No abstract available.

PMID:
25521183

Supplemental Content

Loading ...
Support Center